Breast Revision Surgery in Korea — Umnagumo

Korea — and the Gangnam district of Seoul in particular — has built one of the world’s highest-volume clusters for breast revision surgery, with per-surgeon cumulative revision case loads (capsular contracture correction, implant rupture management, en-bloc capsulectomy, implant exchange, bottoming-out repair, double-capsule revision) that consistently exceed those of Western counterparts. Umnagumo Plastic Surgery operates on 25+ years of clinical experience and 12,000+ cumulative breast surgeries, with revision surgery and post-mastectomy reconstruction as core specialties. Within a single clinic, Umnagumo handles every revision category — Baker I–IV contracture, rupture, rotation, asymmetry, malposition, synmastia, rippling, animation deformity, and aesthetic dissatisfaction from a prior augmentation — and decides capsule management (total capsulectomy, partial capsulectomy, en-bloc removal, or capsule preservation) on the basis of preoperative ultrasound and, where appropriate, MRI. Every revision is performed with endoscopic dissection under board-certified anesthesiologist coverage. Total cost is typically 40–60% lower than equivalent revision in the United States, UK, or Australia even after including flights and accommodation in Seoul. Dr. Soonchan Eom personally responds to all English-language inquiries, including pre-arrival review of prior operative records, implant details, and current symptom photos, so revision planning begins before you travel rather than at the consultation desk.

Revision surgery is technically more demanding than primary augmentation, so the clinic-selection criteria are stricter. The 7 criteria international patients should verify are: (1) Lead surgeon’s cumulative *revision* case count broken down by category (Baker I–IV contracture, rupture management, en-bloc capsulectomy, malposition correction) — not just total breast surgery volume; (2) Routine use of endoscopic dissection — essential for revision because pre-existing scar tissue narrows the operative view; (3) On-site board-certified anesthesiologist for every case (revision operative time is longer, so anesthetic safety management matters more); (4) A written, evidence-based capsule-management protocol that explains when total capsulectomy, partial capsulectomy, en-bloc removal, or capsule preservation is chosen — not a single default; (5) Standardized preoperative imaging (ultrasound for every revision case, MRI when rupture is suspected); (6) Direct English-language communication with the surgeon — agents and coordinators are not sufficient for revision risk discussion; (7) A defined post-operative follow-up protocol with video-call check-ins at 1, 3, 6, and 12 months, plus a clear escalation pathway if complications appear after you return home. Umnagumo satisfies all seven criteria as the Korea branch of Tokyo Nagumo Clinic, with 25+ years and 12,000+ cumulative breast surgeries under Dr. Soonchan Eom.

We generally recommend at least 6 months — typically 10–12 months — after the primary surgery, so that tissue and capsule have stabilized. Implant rupture, severe infection, and Baker IV contracture accompanied by pain may require earlier revision regardless of timing.

We use the Baker classification. Grade I–II is mild — managed with massage, medication, and observation. Grade III involves visible deformity and is treated with capsulectomy + implant exchange. Grade IV is severe, with pain, and requires total capsulectomy + pocket reconstruction.

It depends on the case. Total capsulectomy is selected for Baker IV, silicone leakage, or recurrent contracture. Partial capsulectomy is selected for Baker III or where there is concern about damaging adjacent tissue. For confirmed rupture, en-bloc capsulectomy removes the capsule and implant together.

Effects vary by case: lower contracture recurrence (sub-glandular → sub-muscular / dual-plane), reduced animation deformity (sub-muscular → sub-fascial / dual-plane), and reduced rippling (dual-plane / sub-fascial works better with thin skin).

We need an implant assessment (ultrasound, sometimes MRI), no smoking or alcohol for 1 week beforehand, discontinuation of medications that increase bleeding risk (e.g., aspirin), and information about your primary surgery (implant brand, placement plane, incision location).

Most patients return to daily life within 3–7 days, and exercise is possible from 4–6 weeks post-op. Revision recovery is more variable than primary surgery, so consistent compression and scheduled follow-up are important.

Avoid raising your arms or lifting heavy objects, no sauna or strenuous exercise, no direct pressure on the breast, consistent use of the compression bra as instructed, and regular follow-up visits.

Regular follow-up, no smoking or alcohol, avoiding inflammation-inducing factors, appropriate massage, and prescribed medications all help. Changing implant surface (textured / smooth) and placement plane also influence recurrence rates.